Feed Category: Pharmaceuticals Index

Athira Pharma, Inc.Company Presentation to highlight novel therapeutic candidates targeting the HGF neurotrophic system in late-stage clinical development in neurodegenerative diseases, including Alzheimer’s diseaseBOTHELL, Wash.,… [Read More]

Hepion Pharmaceuticals, Inc.EDISON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic… [Read More]

Tonix Pharmaceuticals Holding Corp.CHATHAM, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a… [Read More]

Athira Pharma, Inc.Presentation to highlight preclinical data from ATH-1105, Athira’s potential treatment candidate for amyotrophic lateral sclerosis (ALS)BOTHELL, Wash., Nov. 28, 2023 (GLOBE NEWSWIRE) –… [Read More]

Ocuphire PharmaMr. Schachle Brings Over 30 Years of Experience in Biotech and Pharma with Expertise Across Multiple Functional Areas Including Corporate and Commercial OperationsFARMINGTON HILLS,… [Read More]

TFF Pharmaceuticals, Inc.FORT WORTH, Texas, Nov. 27, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative… [Read More]

Recent insider trading activity has caught the attention of market analysts and investors alike, as Director Franklin Berger executed a significant purchase of shares in… [Read More]

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 22:BrainsWay Ltd. BWAY: This commercial stage medical device… [Read More]

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Rigel Pharmaceuticals, Inc. RIGL: This biotechnology company has seen the Zacks Consensus… [Read More]

It’s time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth watching this morning!Moving stocks this morning are collaboration agreements,… [Read More]

CAMBRIDGE, Mass., November 21, 2023–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies,… [Read More]

TEL AVIV, Israel, Nov. 20, 2023 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver, metabolic and… [Read More]